For several years, drugmakers have been paying fees when they file new drug applications that the FDA uses to pay its reviewers, under a law called the prescription drug user fee act, or PDUFA. In return, the FDA promises to deliver some decision--even if it's just "needs more data"--by a given date, called the PDUFA date.
FORBES: Medicine's Two-Headed Watchdog